Trials / Completed
CompletedNCT06505408
Impact of a MVM to Support Biomarkers Associated With Conception and Pregnancy in Healthy Women.
Evaluating the Impact of a Multivitamin Supplement to Support Biomarkers Associated With Conception and Pregnancy in Healthy Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Perelel Inc. · Industry
- Sex
- Female
- Age
- 21 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to investigate the effects multivitamin (MVM) on blood biomarkers that are associated with healthy pregnancy and conception in adult women. The main question it aims to answer is: Is there a significant change in blood biomarkers from baseline (week 0) to end of intervention (week 12) in healthy women consuming multivitamin compared to participants consuming the placebo product? Participants will: Take drug MVM or a placebo every day for 12 weeks Visit the clinic at baseline and 12 weeks for serum blood draws and measurements Complete a series of surveys at baseline and 12 weeks
Detailed description
A 12 week double-blind, placebo-controlled, clinical trial assessing the daily administration of a multivitamin (MVM) or placebo on blood biomarkers associated with healthy pregnancy and conception in healthy adult women. Participants will consume study product or placebo for 12 weeks. Measurements will be taken at baseline and at the end of 12 weeks. Primary Objective: To evaluate in healthy women, the effect of 12-week long daily administration of a multivitamin (MVM) on blood biomarkers associated with healthy pregnancy (Folate). Secondary Objective: To evaluate in healthy women, the effect of 12-week long daily administration of multivitamin (MVM) on blood biomarkers associated with healthy pregnancy * Vitamin B12 * Iron * Omega-3 * Choline * CoQ10
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Multivitamin | 4 capsules of Perelel Health Conception Support Multivitamin Pack (consisting of vitamins, minerals, and omega ingredients) consumed daily for 12 weeks |
| DIETARY_SUPPLEMENT | Placebo | 4 placebo capsules consumed daily for 12 weeks |
Timeline
- Start date
- 2024-10-02
- Primary completion
- 2025-01-20
- Completion
- 2025-01-20
- First posted
- 2024-07-17
- Last updated
- 2025-06-06
Locations
1 site across 1 country: Ireland
Source: ClinicalTrials.gov record NCT06505408. Inclusion in this directory is not an endorsement.